We evaluated for copy-number alterations for regions involving commonly altered prostate cancer genes, including the AR gene, tumor suppressors genes (RB1, TP53, and PTEN), and homologous recombination (HR) repair genes (BRCA1, BRCA2, and ATM). This evidence concerns the gene BRCA1 and prostate carcinoma.